WallStreetZen

NYSE: BSX
Boston Scientific Corp Stock

$43.04-0.05 (-0.12%)
Updated May 6, 2021
BSX Price
$43.04
Fair Value Price
N/A
Market Cap
$60.99B
52 Week Low
$32.99
52 Week High
$44.63
P/E
307.43x
P/B
3.88x
P/S
5.42x
PEG
2.09x
Dividend Yield
0%
Revenue
$10.12B
Earnings
$248.00M
Gross Margin
64.9%
Operating Margin
5.71%
Profit Margin
2%
Debt to Equity
0.97
Operating Cash Flow
$2B
Beta
1.03
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

High
Medium
Low
27
Industry average

Reasons for this score

BSX ($43.04) is trading below its intrinsic value of $63.99, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
BSX is poor value based on its earnings relative to its share price (307.43x), compared to the US market average (27.98x)
Valuation
BSX is poor value based on its earnings relative to its share price (307.43x), compared to the US Medical Devices industry average (86.53x)
Valuation

1 of 11

BSX News

Valuation

BSX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
307.43x
Industry
86.53x
Market
27.98x
BSX is poor value based on its earnings relative to its share price (307.43x), compared to the US market average (27.98x)
Valuation
BSX is poor value based on its earnings relative to its share price (307.43x), compared to the US Medical Devices industry average (86.53x)
Valuation

BSX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.88x
Industry
5.1x
Market
0.6x
BSX is poor value based on its book value relative to its share price (3.88x), compared to the US market average (0.6x)
Valuation
BSX is good value based on its book value relative to its share price (3.88x), compared to the US Medical Devices industry average (5.1x)
Valuation

BSX price to earnings growth (PEG)

For valuing profitable companies with growth potential
BSX is poor value relative to its rate of earnings growth, measured by PEG ratio (2.09x)
Valuation

BSX's financial health

Profit margin

Revenue
$2.8B
Net Income
$341.0M
Profit Margin
11.9%
BSX's Earnings (EBIT) of $578.00M are insufficient to safely cover interest payments on company debt ($9.10B)
Financials
BSX's profit margin has decreased (-37.7%) in the last year from (39.7%) to (2%)
Financials

Assets to liabilities

Assets
$30.9B
Liabilities
$15.2B
Debt to equity
0.58
BSX's short-term assets ($6.10B) exceed its short-term liabilities ($3.39B)
Financials
BSX's long-term liabilities ($11.79B) exceed its short-term assets ($6.10B)
Financials
BSX's debt relative to shareholder equity (0.97) has decreased or remained constant compared to 5 years ago (1.74)
Financials
BSX's debt to equity ratio (0.97) is considered high
Financials

Cash flow

Operating
$284.0M
Investing
$71.0M
Financing
-$95.0M
BSX's operating cash flow ($1.87B) is sufficient to service the company's debt ($9.10B)
Financials

Boston Scientific Corp Stock FAQ

What is Boston Scientific Corp's quote symbol?

(NYSE: BSX) Boston Scientific Corp trades on the NYSE under the ticker symbol BSX. Boston Scientific Corp stock quotes can also be displayed as NYSE: BSX.

What is the 52 week high and low for Boston Scientific Corp (NYSE: BSX)?

(NYSE: BSX) Boston Scientific Corp's 52-week high was $44.63, and its 52-week low was $32.99. It is currently -3.56% from its 52-week high and 30.46% from its 52-week low.

How much is Boston Scientific Corp stock worth today?

(NYSE: BSX) Boston Scientific Corp currently has 1,417,165,707 outstanding shares. With Boston Scientific Corp stock trading at $43.04 per share, the total value of Boston Scientific Corp stock (market capitalization) is $60.99B.

Boston Scientific Corp stock was originally listed at a price of $11.47 in Dec 31, 1997. If you had invested in Boston Scientific Corp stock at $11.47, your return over the last 23 years would have been 275.24%, for an annualized return of 5.92%.

How much is Boston Scientific Corp's stock price per share?

(NYSE: BSX) Boston Scientific Corp stock price per share is $43.04 today (as of May 6, 2021).

What is Boston Scientific Corp's Market Cap?

(NYSE: BSX) Boston Scientific Corp's market cap is $60.99B, as of May 9, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Boston Scientific Corp's market cap is calculated by multiplying BSX's current stock price of $43.04 by BSX's total outstanding shares of 1,417,165,707.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.